Search Results - "Morsy, Alaa R I"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Evaluation of some new heterocycles bearing 2‐oxoquinolyl moiety as immunomodulator against highly pathogenic avian influenza virus (H5N8) by El‐Helw, Eman A. E., Morsy, Alaa R. I., Hashem, Ahmed I.

    Published in Journal of heterocyclic chemistry (01-04-2021)
    “…The hydrazide obtained from furan‐2(3H)‐one integrated with a quinolin‐2(1H)‐one core reported previously by our research group was utilized as a building…”
    Get full text
    Journal Article
  2. 2

    Antiviral activity of pyrazole derivatives bearing a hydroxyquinoline scaffold against SARS-CoV-2, HCoV-229E, MERS-CoV, and IBV propagation by Morsy, Alaa R I, Mahmoud, Sara H, Abou Shama, Noura M, Arafa, Walaa, Yousef, Gehad A, Khalil, Ahmed A, Ramadan, Sayed K

    Published in RSC advances (29-08-2024)
    “…The ongoing global threat posed by coronaviruses necessitates the urgent development of effective antiviral agents. In this study, we investigated the…”
    Get full text
    Journal Article
  3. 3

    Synthesis and biological activity on IBD virus of diverse heterocyclic systems derived from 2-cyano-N'-((2-oxo-1,2-dihydroquinolin-3-yl)methylene)acetohydrazide by Kaddah, Mohamed M., Morsy, Alaa R. I., Fahmi, Abdelgawad A., Kamel, Mustafa M., Elsafty, Mounir M., Rizk, Sameh A., Ramadan, Sayed K.

    Published in Synthetic communications (17-11-2021)
    “…A 2-cyano-N'-((2-oxo-1,2-dihydroquinolin-3-yl)methylene)ethanohydrazide (3) was synthesized in 87% yield via condensation of 3-formyl-2-oxoquinoline (1) with…”
    Get full text
    Journal Article
  4. 4

    Synthesis and antiviral activity of some pyrrolonyl substituted heterocycles as additives to enhance inactivated Newcastle disease vaccine by Morsy, Alaa R. I., Ramadan, Sayed K., Elsafty, Mounir M.

    Published in Medicinal chemistry research (01-06-2020)
    “…This research reported the design and synthesis of some influential new pyrrolone derivatives bearing a pyrazole scaffold with the evaluation of their…”
    Get full text
    Journal Article
  5. 5

    Efficacy of some avian influenza H5 vaccines against local highly pathogenic avian influenza viruses subtype H5N8 isolated in 2018 and 2020 in Egypt by Mounir M Elsafty, Alaa RI Morsy, Marwa Fathy Elsayed, Reem A Soliman, Mahmoud M Abotaleb

    Published in Vaccimonitor (01-02-2023)
    “…Commercial inactivated avian influenza H5 vaccine is used as an essential control strategy for avian influenza disease in Egypt. Since the initial outbreaks of…”
    Get full text
    Journal Article